Editor's Note: For more information on the Duke University polio trial or other brain cancer trials, click here or call the Preston Robert Tisch Brain Tumor Center at Duke 919-684-5301 The following ...

A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, with a three-year survival rate ...

A technique developed several years ago at Duke University involving an engineered hybrid of poliovirus and rhinovirus has shown great promise in treating a lethal form of brain cancer. A new study ...

One of the world's most dreaded viruses has been turned into a treatment to fight deadly brain tumors. Survival was better than expected for patients in a small study who were given genetically ...

Mass campaigns with oral poliovirus vaccine (OPV) have brought the world close to the eradication of wild poliovirus. However, to complete eradication, OPV must itself be withdrawn to prevent ...

Chennai, Feb. 17 -- Highlights: ...

An inactivated form of the poliovirus used to treat recurrent brain tumors is showing what researchers called encouraging long-term survival in a Phase 1 clinical trial published Tuesday. The authors ...

"Oncolytic virus therapy" uses human viruses to fight cancer. Glioblastoma is a type of brain cancer that has recently been quite visible in the media after Sen. John McCain was treated for it.

In 1988, the World Health Assembly resolved to eradicate poliomyelitis. Although substantial progress toward this goal has been made, eradication remains elusive. In 2004, the World Health ...

The dreaded poliovirus belongs to the same large family, enteroviruses, as several common colds. It has been known for some time that enteroviruses drastically rearrange the inside of infected, but it ...